Alexander Hardy
Chief Executive Officer en BIOMARIN PHARMACEUTICAL INC. .
Fortuna: 13 M $ al 31/03/2024
Perfil
Alexander Hardy is currently the President, Chief Executive Officer & Director at BioMarin Pharmaceutical, Inc. He is also a Director at Pharmaceutical Research & Manufacturers of America and a Member of The Wall Street Journal CEO Council.
Previously, he was the Chief Executive Officer & Director at Genentech, Inc. Hardy received his undergraduate degree from the University of Cambridge and his MBA from the Stephen M.
Ross School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/03/2024 | 148 151 ( 0.08% ) | 13 M $ | 31/03/2024 |
Cargos activos de Alexander Hardy
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Chief Executive Officer | 01/12/2023 |
| The Wall Street Journal CEO Council | Corporate Officer/Principal | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Director/Board Member | - |
Antiguos cargos conocidos de Alexander Hardy.
| Empresas | Cargo | Fin |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Executive Officer | - |
Formación de Alexander Hardy.
| University of Cambridge | Undergraduate Degree |
| Stephen M. Ross School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
| The Wall Street Journal CEO Council |
- Bolsa de valores
- Insiders
- Alexander Hardy
